Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery

Launched by ZHEJIANG UNIVERSITY · Dec 1, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new surgical technique for removing certain types of benign or borderline pancreatic tumors while minimizing blood loss during the procedure. The researchers are testing a method that involves blocking the blood supply to the pancreas using special clips, which can help preserve more healthy tissue and reduce the risk of the tumor coming back. This approach is particularly focused on tumors located in the head, neck, and uncinate process of the pancreas, which are known to have a rich blood supply that can make surgery challenging.

To be eligible for this trial, participants should be diagnosed with specific types of benign tumors, such as pancreatic neuroendocrine tumors or cystadenomas, and must not have tumors that have spread or invaded nearby blood vessels. The trial is currently recruiting individuals aged 18 and older, regardless of gender. Participants can expect to undergo laparoscopic surgery, which is a minimally invasive technique that may lead to quicker recovery times. It's important to note that those with highly malignant tumors or tumors in different parts of the pancreas will not be eligible for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Benign or borderline tumors diagnosed pathologically, such as pancreatic neuroendocrine tumors, solid pseudopapillary tumors, and cystadenomas, without vascular invasion or distant metastasis
• • Tumors sited in the pancreatic head, neck, and uncinate process of pancreas
• • Blockade of both the abdominal trunk and superior mesenteric artery in the laparoscopic enucleation
• Exclusion Criteria:
• • Highly malignant pancreatic tumors, or tumors with infiltration or metastasis
• • Tumors of the body and tail of the pancreas
• • Transfer to LPD or laparotomy